ActiManTIDE PLUS forte 18+: A European study on improving men's sexual health.
The survey was conducted in April-May 2022. It was carried out by certified specialists from the Regenerative Medicine and Nutritional Medicine Department of the European Scientific Society at the Academy of Natural Sciences (Hanover).
The anonymous survey involved 15 patients (aged 37-59) who complained of decreased sexual activity due to various illnesses, long-term stress, a sedentary lifestyle, or prolonged abstinence.
Patients were offered a 30-day course of the multi-component peptide bioregulator "ActiManTIDE PLUS forte 18+", taking one capsule per day. After completing the course, all patients without exception, and some even during the course, reported a significant increase in libido, stronger erections, and increased sexual activity. The quality of sexual intercourse significantly improved, as pelvic floor muscles gained tone, penile sensitivity increased, and the duration of intercourse lengthened. Improved erections were observed even in patients who had previously experienced complete erectile dysfunction.
All patients experienced improved overall well-being and mood, reduced nervousness, and increased resilience to stressful situations. No side effects from the bioregulator were observed, nor were any cardiac or hepatic complications or changes in their function detected. After discontinuation of the bioregulator, patients' sexual activity and libido did not return to their initial levels.
Source of information: https://myrealway.com/actimantide-peptides-for-erectile-dysfunction
